Neoadjuvant Pegylated Liposomal Doxorubicin-Containing Chemotherapy in Combination with Trastuzumab and Pertuzumab in Patients with HER2-positive Early Breast Cancer: A Randomized Phase II Study (METIS).
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined